In January 2020, the novel coronavirus (COVID-19) outbreak emerged in China, prompting the enforcement of stringent lockdown measures nationwide to contain its spread. Multiple studies have demonstrated that these measures successfully reduced the levels of air pollutants except for ozone (O). However, the potential risks of nationwide O changes during this period remain uncertain. To address this gap, we evaluated the ecological and health effects of O using hourly O data from 1 January to 17 June in both 2020 and 2019. Our results indicated that all health and ecological indicators, except SUM06 (sum of all hourly O over 60 ppb), during the COVID-19 pandemic in 2020 increased most obviously in Stages 2 and 3 with the strictest control measures, compared to the same period in 2019. The national premature deaths due to short-term O exposure during Stages 2-3 in 2020 totaled 146,558 (95% CI: 79,386-213,730) for all non-accidental causes and 82,408 (95% CI: 30,522-134,295) for cardiovascular diseases, increasing by 18.78% and 18.76% in 2019, respectively. The most significant increase in health risks occurred in Hubei, followed by Jiangxi, Zhejiang, Hunan, and Shaanxi. In addition, the estimated national winter wheat production losses (WWPL) attributable to O amounted to 50.6 and 51.1 million metric tons for 2019 and 2020, respectively. Among the major winter wheat-producing provinces, Anhui and Jiangsu experienced a larger increase in WWPL, while Shandong and Hebei suffered a greater decrease in 2020 compared to 2019, resulting in little overall change in WWPL between the two years. These findings provided direct evidence of the harmful effects of O during the COVID-19 pandemic and serve as a valuable reference for future air pollution control.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envpol.2023.122713DOI Listing

Publication Analysis

Top Keywords

covid-19 pandemic
12
health risks
8
winter wheat
8
0
6
1
5
increased ground-level
4
covid-19
4
ground-level covid-19
4
pandemic china
4
china aggravates
4

Similar Publications

Background: Dexamethasone has proven life-saving in severe acute respiratory syndrome (SARS) and COVID-19 cases. However, its systemic administration is accompanied by serious side effects. Inhalation delivery of dexamethasone (Dex) faces challenges such as low lung deposition, brief residence in the respiratory tract, and the pulmonary mucus barrier, limiting its clinical use.

View Article and Find Full Text PDF

This research investigates the moral frames employed by diverse Chinese-speaking "experts" on their Facebook public pages in relation to COVID-19 vaccines, leveraging Moral Foundations Theory for analysis. The analysis highlights that experts predominantly employ moral frames emphasizing care and authority in communicating COVID-19 vaccines. However, the moral frames of care, loyalty, and fairness are more effective in garnering public support.

View Article and Find Full Text PDF

Background: Cognitive function decline is a problem in aging people living with HIV (PLWHIV). COVID-19 infection is associated with neuropsychiatric manifestations that may persist. The aim of our study was to evaluate cognitive function in PLWHIV before and after COVID-19 infection.

View Article and Find Full Text PDF

Human noroviruses (HNoVs) are a leading cause of acute gastroenteritis worldwide, with significant public health implications. In this study, wastewater-based epidemiology (WBE) was used to monitor the circulation and genetic diversity of HNoVs in Rome over an eight-year period (2017-2024). A total of 337 wastewater samples were analyzed using RT-nested PCR and next-generation sequencing (NGS) to identify genogroups GI and GII and their respective genotypes.

View Article and Find Full Text PDF

Second-generation integrase strand transfer inhibitors (INSTIs) are strongly recommended for people living with HIV-1 (PLWH). The emergence of resistance to second-generation INSTIs has been infrequent and has not yet been a major issue in high-income countries. However, the delayed rollouts of these INSTIs in low- to middle-income countries during the COVID-19 pandemic combined with increased transmission of drug-resistant mutants worldwide are leading to an increase in INSTI resistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!